Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP724473.RA0ATgZhu-Enhcv-ipGoIstHk4fgYGBFF_J4C4rQ-4Akw130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP724473.RA0ATgZhu-Enhcv-ipGoIstHk4fgYGBFF_J4C4rQ-4Akw130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP724473.RA0ATgZhu-Enhcv-ipGoIstHk4fgYGBFF_J4C4rQ-4Akw130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP724473.RA0ATgZhu-Enhcv-ipGoIstHk4fgYGBFF_J4C4rQ-4Akw130_provenance.
- NP724473.RA0ATgZhu-Enhcv-ipGoIstHk4fgYGBFF_J4C4rQ-4Akw130_assertion description "[Activating mutations of class III receptor tyrosine kinases (RTK) FLT3, PDGFR and KIT are associated with multiple human neoplasms including hematologic malignancies, for example: systemic mast cell disorders (KIT), non-CML myeloproliferative neoplasms (PDGFR) and subsets of acute leukemias (FLT3 and KIT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP724473.RA0ATgZhu-Enhcv-ipGoIstHk4fgYGBFF_J4C4rQ-4Akw130_provenance.
- NP724473.RA0ATgZhu-Enhcv-ipGoIstHk4fgYGBFF_J4C4rQ-4Akw130_assertion evidence source_evidence_literature NP724473.RA0ATgZhu-Enhcv-ipGoIstHk4fgYGBFF_J4C4rQ-4Akw130_provenance.
- NP724473.RA0ATgZhu-Enhcv-ipGoIstHk4fgYGBFF_J4C4rQ-4Akw130_assertion SIO_000772 23497317 NP724473.RA0ATgZhu-Enhcv-ipGoIstHk4fgYGBFF_J4C4rQ-4Akw130_provenance.
- NP724473.RA0ATgZhu-Enhcv-ipGoIstHk4fgYGBFF_J4C4rQ-4Akw130_assertion wasDerivedFrom befree-20140225 NP724473.RA0ATgZhu-Enhcv-ipGoIstHk4fgYGBFF_J4C4rQ-4Akw130_provenance.
- NP724473.RA0ATgZhu-Enhcv-ipGoIstHk4fgYGBFF_J4C4rQ-4Akw130_assertion wasGeneratedBy ECO_0000203 NP724473.RA0ATgZhu-Enhcv-ipGoIstHk4fgYGBFF_J4C4rQ-4Akw130_provenance.
- befree-20140225 importedOn "2014-02-25" NP724473.RA0ATgZhu-Enhcv-ipGoIstHk4fgYGBFF_J4C4rQ-4Akw130_provenance.